Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cibus, Inc. CBUS

Healthcare  —  Biotechnology
1.52 0.02 1.33% as of 25 Sep
Market cap
$114.6M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Cibus, Inc. (CBUS) Business Profile

Updated before January 2025

Company Overview

Cibus, Inc. (CBUS) is a pioneering agricultural biotechnology company that specializes in developing innovative solutions for crop improvement. Founded in 2001 and headquartered in San Diego, California, Cibus has established itself as a leader in precision gene editing technologies. The company was co-founded by Dr. Keith Walker, a molecular biologist, and Dr. Rory Riggs, a seasoned entrepreneur with a background in biotechnology. Under the leadership of CEO Rory Riggs, Cibus has grown into a globally recognized name in the agricultural sector, with a mission to revolutionize farming practices and enhance food security.

Cibus’s core technology, known as the Rapid Trait Development System (RTDS), enables precise and targeted genetic modifications in plants without introducing foreign DNA. This approach aligns with the company’s commitment to sustainability and natural crop improvement. Over the years, Cibus has partnered with leading agricultural companies and research institutions to bring its innovative solutions to market.

Core Business Segments

Cibus operates across several core business segments, each focused on addressing critical challenges in agriculture. These segments include:

1. Crop Trait Development

Cibus’s flagship offering is its portfolio of crop traits developed using RTDS. These traits are designed to improve crop yield, resistance to pests and diseases, and tolerance to environmental stresses such as drought and salinity. Key products in this category include:

  • Disease Resistance Traits: Enhancing crops’ natural ability to resist fungal, bacterial, and viral infections.
  • Herbicide Tolerance Traits: Allowing farmers to use specific herbicides without harming the crops.
  • Yield Enhancement Traits: Increasing the productivity of staple crops like corn, soybeans, and canola.

2. Licensing and Partnerships

Cibus collaborates with seed companies and agricultural firms to license its proprietary traits. This segment generates revenue through licensing agreements and royalties, enabling Cibus to scale its impact globally.

3. Research and Development Services

Cibus offers R&D services to agricultural companies seeking to develop custom traits for their crops. This includes gene editing, trait validation, and regulatory support.

Business Model

Cibus’s business model is built on leveraging its proprietary RTDS technology to create value for farmers, seed companies, and the broader agricultural ecosystem. The company generates revenue through:

  • Trait Licensing: Licensing its traits to seed companies for commercialization.
  • Collaborative Partnerships: Partnering with agricultural firms to co-develop new traits and share revenues.
  • R&D Services: Providing specialized gene editing and trait development services to third parties.

Cibus’s approach emphasizes sustainability, cost-effectiveness, and scalability. By focusing on non-GMO solutions, the company appeals to markets with stringent regulatory requirements and consumer preferences for natural products.

Strategic Direction

Cibus is committed to driving innovation in agriculture while addressing global challenges such as climate change, food security, and sustainable farming. Key elements of its strategic direction include:

  • Expansion of Trait Portfolio: Developing new traits for a broader range of crops, including wheat, rice, and specialty crops.
  • Global Market Penetration: Expanding its presence in emerging markets with high agricultural potential.
  • Sustainability Goals: Reducing the environmental impact of farming through traits that require fewer inputs like water, fertilizers, and pesticides.
  • Technological Advancements: Investing in next-generation gene editing technologies to enhance the precision and efficiency of its solutions.

Competitive Landscape

Cibus operates in a competitive landscape that includes both traditional seed companies and biotech firms specializing in gene editing. Key competitors include:

  • Corteva Agriscience: A major player in agricultural biotechnology with a focus on seed and crop protection products.
  • Bayer Crop Science: Known for its extensive portfolio of genetically modified seeds and crop protection solutions.
  • Syngenta: A global leader in agricultural innovation, offering a wide range of seeds and agrochemicals.
  • Benson Hill: A biotech company specializing in crop improvement through data-driven approaches.

Cibus differentiates itself through its non-GMO approach and focus on natural trait development, which appeals to markets with strict regulatory frameworks and consumer demand for sustainable solutions.

Risk Factors

Despite its strengths, Cibus faces several risks that could impact its business:

  • Regulatory Challenges: Navigating complex and varying regulatory environments for gene-edited crops.
  • Market Dependence: Reliance on a limited number of key crops and markets for revenue.
  • Supply Chain Disruptions: Potential disruptions in the supply of raw materials and distribution channels.
  • Technological Competition: The risk of competitors developing superior gene editing technologies.

Recent Developments

Cibus has made significant strides in recent years, including:

  • New Trait Launches: Introduction of drought-tolerant traits for corn and disease-resistant traits for soybeans.
  • Strategic Partnerships: Collaboration with leading seed companies to expand the adoption of its traits.
  • Regulatory Milestones: Achieving regulatory approval for its non-GMO traits in key markets such as the United States, Canada, and the European Union.
  • Sustainability Initiatives: Launching programs to promote sustainable farming practices among its customers.

Investment Considerations

Investors considering Cibus should weigh the following factors:

Strengths

  • Innovative Technology: Proprietary RTDS technology with broad applications.
  • Market Leadership: Strong position in the non-GMO crop trait market.
  • Growth Potential: Opportunities for expansion into new crops and markets.
  • Sustainability Focus: Alignment with global trends toward sustainable agriculture.

Risks

  • Regulatory Uncertainty: Potential delays or rejections in regulatory approvals.
  • Competitive Pressure: Intense competition from established players and emerging startups.
  • Market Volatility: Dependence on agricultural markets, which are subject to fluctuations.

Conclusion

Cibus, Inc. is at the forefront of agricultural innovation, leveraging its cutting-edge gene editing technology to address critical challenges in farming. With a strong focus on sustainability, a growing portfolio of traits, and strategic partnerships, Cibus is well-positioned for future growth. However, investors should carefully consider the risks associated with regulatory hurdles and market dynamics. Overall, Cibus represents a compelling opportunity for those seeking exposure to the agricultural biotechnology sector.